CClinicalTrials.gg
RecruitingNCT04912739Updated Sep 29, 2026

Targeted Health Dialogues in Primary Care

An observational study in Health Behaviors, Risk Factors and Cardiovascular Diseases, sponsored by Region Skane. Recruiting at 1 site in Sweden. Open to participants aged 40 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-09-29.

Sponsored by Region Skane · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
18,000
Ages
40 Years to 70 Years
Sex
All
01

Study summary

The County Council of Region Skåne, Sweden, has recently initiated Targeted Health Dialogues in primary care. The prevention program includes health dialogues provided by specially trained personnel, collection of clinical and laboratory data as well as questionnaire data on, e.g., individual health and health behaviors. So far, it enrolls all 40-year old Swedish and foreign-born inhabitants in the county and it will also include all 50- and 60-year old persons within a near future. A research project will be integrated within the program where the collected data will be linked, on the individual level, to national and regional data on hospital admissions, clinical diagnoses from specialist clinics and primary care, causes of death, and prescriptions. The individual linkages will also include population data on sociodemographic characteristics, neighborhood of residence and family relations. Blood samples will be collected for analyses of molecular biomarkers. The research project will examine associations between potential predictors and future risk of cardiovascular diseases and other serious diseases, such as cancer, and also whether the effect of the prevention program is modified by these potential predictors. The effect of the intervention will be examined, and whether the protocol needs to be modified in order to develop more precise and personalized medicine.

Read the detailed description

The County Council of Region Skåne, the third most populous region in Sweden with 1.4 million inhabitants, has recently initiated Targeted Health Dialogues in primary care with the ultimate goal to improve cardiovascular health in the entire population in Skåne. Targeted health dialogues have previously been proven to improve health behaviors and risk factors and decrease the incidence of cardiovascular disease and mortality. The prevention program includes, in addition to the health dialogues provided by specially trained personnel, collection of clinical and laboratory data (e.g. blood pressure, BMI, waist hip ratio, lipids, fasting blood glucose) as well as detailed questionnaire data on, e.g., individual health and symptoms, family history, diet, physical activity, alcohol and smoking. So far, it enrolls all 40-year old Swedish and foreign-born inhabitants in the county and it will also include all 50- and 60-year old persons within a near future. The County Council and the Ethical Review Board have granted permission to integrate a research project within the program where collected data will be linked, at the individual level, to national and regional data on hospital admissions, clinical diagnoses from specialist clinics and primary care, causes of death, and prescriptions. The individual linkages will also include population data on sociodemographic characteristics, neighborhood of residence and family relations. In addition to the collection and linkages of these data, blood samples will be collected for analyses of molecular biomarkers. The research project will allow for examining associations between a number of potential predictors and future risk of cardiovascular disease and other serious diseases, such as cancer, and also whether the effect of the prevention program is modified by these potential predictors. The effect of the intervention will be examined and whether the protocol needs to be modified in order to develop more precise and personalized medicine.

02

Conditions studied

  • Health Behaviors
  • Risk Factors
  • Cardiovascular Diseases
  • Cancer
  • Serious Diseases
03

Who can participate

Ages eligible
40 Years to 70 Years
Sexes eligible
All
Sampling method
Probability sample

Study population

In Sweden, most people are listed at one healthcare center. The study population consists of all listed 40-, 50-, 60-year, and 70-year-old patients that perform a targeted health dialogue and consent to take part in the research study.

Inclusion criteria

  • 40-, 50-, 60-, and 70-year old men and women
  • Listed at a healthcare center in Skåne county

Exclusion criteria

Exclusion Criteria:

* Inability to understand the written study information and give informed consent

04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
18,000 participants (estimated)
Patient registry
No
Biospecimen retention
Samples with dna

Interventions

  • BehavioralTargeted health dialogues

    Before the targeted health dialogue, the participants fill in a questionnaire about health behaviors, background characteristics and self-rated health. Samples for blood glucose and total cholesterol are taken. BMI, waist-to-hip ratio and blood pressure are measured. The results are summoned in a "health curve", which is discussed with specially trained healthcare personnel in a Targeted heath dialogue. In a sub-group, blood samples are collected for molecular analyses.

05

What researchers measure

Primary outcomes

  1. Effect of targeted health dialogues on CVD incidence

    The short- and long-term effect of targeted health dialogues on incidence of CVD events, its comorbidity and CVD-related deaths in the participants compared to a general population cohort and historical controls.

    Time frame: 2035

  2. Effect of targeted health dialogues on incidence of cancer and other serious diseases

    The short- and long-term effect of targeted health dialogues on incidence of cancer and other serious diseases in the participants compared to a general population cohort and historical controls.

    Time frame: 2035

Secondary outcomes

  1. Modification by individual characteristics

    Modification of possible associations between targeted health dialogues and future CVD, cancer, other serious diseases and preterm death by individual characteristics (e.g., sociodemographic factors)

    Time frame: 2035

  2. Association between risk factors and disease incidence

    Associations between risk factors/combination of risk factors (lifestyle-related, metabolic, psychosocial and familial) at baseline and incidence of CVD, cancer, other serious diseases and preterm death.

    Time frame: 2035

  3. Identification of molecular biomarkers

    The ability of biological aging, epigenetic changes and genetic and metabolomic profiles to predict CVD, cancer, other serious diseases and preterm death as well as the effect of targeted health dialogues.

    Time frame: 2035

  4. Public health profile of middle-aged citizens in Sweden's southernmost county

    Level of physical activity and sedentary behavior, intake of healthy/unhealthy food, alcohol consumption, smoking habits, stress, psychological well-being, blood glucose, cholesterol, BMI, waist-hip ratio. Comparisons between subgroups: age, sex, sociodemography, previous diagnoses.

    Time frame: 2035

  5. Associations between dental and general health

    Associations between dental health at baseline and incidence of CVD, cancer, other serious diseases and preterm death.

    Time frame: 2035

  6. Validation of the targeted health dialogue method

    Validity and reliability of the questionnaire and targeted health dialogue method

    Time frame: 2035

  7. Health economy

    Costs related to the targeted health dialogues versus individual and societal gains.

    Time frame: 2035

  8. The effect of targeted health dialogues on health behaviors and self-rated health

    Time frame: 2035

  9. Do targeted health dialogues reach all societal groups?

    Time frame: 2035

  10. Can other lifestyle interventions influence the effect of targeted health dialogues?

    Time frame: 2035

  11. Follow-up of samples taken after the targeted health dialogues.

    Which samples and tests were taken as a result of the targeted health dialogues?

    Time frame: 2035

  12. Do the the targeted health dialogues influence care seeking?

    Evaluation of new search patterns due to the targeted health dialogues.

    Time frame: 2035

  13. Obstacles and motivators for physical activity

    What obstacles and motivators for physical activity do inactive people experience?

    Time frame: 2035

  14. Effect of targeted health dialogues on blood metabolites

    Do targeted health dialogues affect food-related metabolites in the blood?

    Time frame: 2035

06

Study locations

1 of 1 sites recruiting
  • Center for Primary Health Care Research, Lund University and Region Skåne
    Malmö, Skåne County 20502, Sweden
    Recruiting
07

References and documents

Publications

  • Nymberg P, Milos-Nymberg V, Grundberg A, Oscarson N, Stenman E, Sundquist K. Exploring the link between self-rated poor oral health and cardiovascular risk: a cross-sectional study using SCORE2. BMC Oral Health. 2025 Feb 24;25(1):298. doi: 10.1186/s12903-025-05671-6. PubMed 39994610 ↗
  • Stenman E, Borgstrom Bolmsjo B, Grundberg A, Sundquist K. Health determinants among participants in targeted health dialogues offered to all 40-year-old individuals in a metropolitan region of 1.4 million people. Scand J Prim Health Care. 2025 Mar;43(1):24-35. doi: 10.1080/02813432.2024.2385547. Epub 2024 Aug 1. PubMed 39091122 ↗
08

Registry details

Key details

Study ID
NCT04912739
Lead sponsor
Region Skane
Responsible party
Sponsor
First posted
Jun 3, 2021
Start date
Oct 1, 2020
Primary completion
Dec 31, 2030 (estimated)
Completion
Dec 31, 2040 (estimated)
Last update
Sep 29, 2026

Study contacts

Kristina Sundquist, PhD, MD
Contact
kristina.sundquist@med.lu.se
+46 (0)40 391 376
Emelie Stenman, PhD
Contact
emelie.stenman@med.lu.se
+46 (0)702 900 920
Kristina Sundquist, PhD, MD
principal investigator · Center for Primary Health Care Research, Department of Clinical Sciences Malmö, Lund University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion